Fanwood, NJ, United States of America

George A Doldouras

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1982.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of George A Doldouras

Introduction

George A Doldouras is a notable inventor based in Fanwood, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of novel compounds and processes. His work has led to the granting of a patent that showcases his innovative approach to resolving complex chemical mixtures.

Latest Patents

Doldouras holds a patent for "Acid addition salts of N-trityl-.alpha.-fluoromethylhistidine enantiomer." This patent describes a process for resolving a mixture of .alpha.-fluoromethylhistidine enantiomers. The process features the use of an ester derivative of .alpha.-fluoromethylhistidine. Additionally, novel diastereoisomer salts of said derivative are disclosed, highlighting the uniqueness of his invention.

Career Highlights

George A Doldouras is associated with Merck & Company, Inc., a leading global healthcare company. His role at Merck has allowed him to work on cutting-edge research and development projects. His contributions have been instrumental in advancing the company's mission to improve health outcomes through innovative solutions.

Collaborations

Throughout his career, Doldouras has collaborated with esteemed colleagues such as Janos Kollonitsch and Leroy M Perkins. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

George A Doldouras exemplifies the spirit of innovation through his patent and contributions to the pharmaceutical industry. His work continues to influence the field of chemistry and demonstrates the importance of collaboration in achieving groundbreaking results.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…